| Year |
Citation |
Score |
| 2023 |
Khattak MA, Iqbal Z, Nasir F, Neau SH, Khan SI, Hidayatullah T, Pervez S, Sakhi M, Zainab SR, Gohar S, Alasmari F, Rahman A, Maryam GE, Tahir A. Tamoxifen-Loaded Eudragit Nanoparticles: Quality by Design Approach for Optimization of Nanoparticles as Delivery System. Pharmaceutics. 15. PMID 37896131 DOI: 10.3390/pharmaceutics15102373 |
0.407 |
|
| 2021 |
Khan FU, Nasir F, Iqbal Z, Neau S, Khan I, Hassan M, Iqbal M, Ullah A, Khan SI, Sakhi M. Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization, and Evaluation. Iranian Journal of Pharmaceutical Research : Ijpr. 20: 592-608. PMID 34904011 DOI: 10.22037/ijpr.2021.114478.15054 |
0.324 |
|
| 2019 |
Butt S, Hasan SMF, Hassan MM, Alkharfy KM, Neau SH. Directly compressed rosuvastatin calcium tablets that offer hydrotropic and micellar solubilization for improved dissolution rate and extent of drug release. Saudi Pharmaceutical Journal : Spj : the Official Publication of the Saudi Pharmaceutical Society. 27: 619-628. PMID 31297015 DOI: 10.1016/J.Jsps.2019.03.002 |
0.438 |
|
| 2018 |
Altamimi MA, Neau SH. A study to identify the contribution of Soluplus® component homopolymers to the solubilization of nifedipine and sulfamethoxazole using the melting point depression method Powder Technology. 338: 576-585. DOI: 10.1016/J.Powtec.2018.07.027 |
0.446 |
|
| 2017 |
Pinto CA, Saripella KK, Loka NC, Neau SH. Development and Characterization of Chitosan Cross-Linked With Tripolyphosphate as a Sustained Release Agent in Tablets, Part I: Design of Experiments and Optimization. Journal of Pharmaceutical Sciences. PMID 29183743 DOI: 10.1016/J.Xphs.2017.11.018 |
0.746 |
|
| 2017 |
Loka NC, Saripella KK, Pinto CA, Neau SH. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization. Drug Development and Industrial Pharmacy. 1-11. PMID 29183166 DOI: 10.1080/03639045.2017.1405975 |
0.698 |
|
| 2017 |
Altamimi MA, Neau SH. Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization. Saudi Pharmaceutical Journal : Spj : the Official Publication of the Saudi Pharmaceutical Society. 25: 419-439. PMID 28344498 DOI: 10.1016/J.Jsps.2016.09.013 |
0.497 |
|
| 2016 |
Valle BL, Omwancha WS, Neau SH, Wigent RJ. Use of к-Carrageenan, Chitosan and Carbopol® 974P in Extruded and Spheronized Pellets That are Devoid of MCC. Drug Development and Industrial Pharmacy. 1-40. PMID 27100683 DOI: 10.1080/03639045.2016.1181647 |
0.745 |
|
| 2016 |
Altamimi MA, Neau SH. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus. Drug Development and Industrial Pharmacy. 42: 446-55. PMID 26289001 DOI: 10.3109/03639045.2015.1075033 |
0.414 |
|
| 2016 |
Saripella KK, Loka NC, Mallipeddi R, Rane AM, Neau SH. A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone(®) XL-10. Aaps Pharmscitech. 17: 368-79. PMID 26169900 DOI: 10.1208/S12249-015-0345-6 |
0.716 |
|
| 2015 |
Altamimi MA, Neau SH. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus. Drug Development and Industrial Pharmacy. 1-10. PMID 26266965 DOI: 10.3109/03639045.2015.1075033 |
0.302 |
|
| 2014 |
Mallipeddi R, Saripella KK, Neau SH. Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization. Saudi Pharmaceutical Journal : Spj : the Official Publication of the Saudi Pharmaceutical Society. 22: 360-72. PMID 25161381 DOI: 10.1016/J.Jsps.2013.11.001 |
0.714 |
|
| 2014 |
Saripella KK, Mallipeddi R, Neau SH. Crospovidone interactions with water. II. Dynamic vapor sorption analysis of the effect of Polyplasdone particle size on its uptake and distribution of water. International Journal of Pharmaceutics. 475: 174-80. PMID 25152165 DOI: 10.1016/J.Ijpharm.2014.08.040 |
0.619 |
|
| 2014 |
Saripella KK, Mallipeddi R, Neau SH. Crospovidone interactions with water. I. Calorimetric study of the effect of Polyplasdone particle size on its uptake and distribution of water. Journal of Pharmaceutical Sciences. 103: 669-75. PMID 24395756 DOI: 10.1002/Jps.23846 |
0.593 |
|
| 2014 |
Kouba C, DiGuilio K, Valenzano C, Mullin J, Neau S. A Cell Culture Model for Oral Administration of Tegafur for Topical Drug Delivery to Colon Adenocarcinoma American Journal of Gastroenterology. 109: S212. DOI: 10.14309/00000434-201410002-00731 |
0.409 |
|
| 2013 |
Omwancha WS, Mallipeddi R, Valle BL, Neau SH. Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA. International Journal of Pharmaceutics. 441: 343-51. PMID 23200955 DOI: 10.1016/J.Ijpharm.2012.11.022 |
0.721 |
|
| 2013 |
Mughal MA, Saripella KK, Kouba C, Iqbal Z, Neau SH. Coated hydralazine hydrochloride beads for sustained release after oral administration. Drug Development and Industrial Pharmacy. 39: 1439-46. PMID 23057650 DOI: 10.3109/03639045.2012.719904 |
0.519 |
|
| 2011 |
Fouad EA, El-Badry M, Mahrous GM, Alanazi FK, Neau SH, Alsarra IA. The use of spray-drying to enhance celecoxib solubility. Drug Development and Industrial Pharmacy. 37: 1463-72. PMID 21707230 DOI: 10.3109/03639045.2011.587428 |
0.402 |
|
| 2011 |
Alsarra IA, Hamed AY, Alanazi FK, Neau SH. Rheological and mucoadhesive characterization of poly(vinylpyrrolidone) hydrogels designed for nasal mucosal drug delivery. Archives of Pharmacal Research. 34: 573-82. PMID 21544722 DOI: 10.1007/S12272-011-0407-6 |
0.373 |
|
| 2011 |
Alanazi FK, Harisa Gel-D, Maqboul A, Abdel-Hamid M, Neau SH, Alsarra IA. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study. Archives of Pharmacal Research. 34: 563-71. PMID 21544721 DOI: 10.1007/S12272-011-0406-7 |
0.381 |
|
| 2011 |
Fouad EA, El-Badry M, Neau SH, Alanazi FK, Alsarra IA. Technology evaluation: Kollicoat IR. Expert Opinion On Drug Delivery. 8: 693-703. PMID 21417781 DOI: 10.1517/17425247.2011.566266 |
0.342 |
|
| 2011 |
Omwancha W, Kouba C, Yelamanchili S, Neau SH. Colon-specific drug delivery using ethylcellulose and chitosan in the coat of compression-coated tablets. Drug Development and Industrial Pharmacy. 37: 945-53. PMID 21417614 DOI: 10.3109/03639045.2010.551773 |
0.73 |
|
| 2011 |
Mughal MA, Iqbal Z, Neau SH. Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride Aaps Pharmscitech. 12: 77-87. PMID 21174179 DOI: 10.1208/S12249-010-9570-1 |
0.464 |
|
| 2010 |
Alsarra IA, Alanazi FK, Ahmed SM, Bosela AA, Alhamed SS, Mowafy HA, Neau SH. Comparative study of itraconazole-cyclodextrin inclusion complex and its commercial product. Archives of Pharmacal Research. 33: 1009-17. PMID 20661710 DOI: 10.1007/S12272-010-0706-3 |
0.389 |
|
| 2010 |
Mallipeddi R, Saripella KK, Neau SH. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization. International Journal of Pharmaceutics. 385: 53-65. PMID 19853027 DOI: 10.1016/J.Ijpharm.2009.10.028 |
0.704 |
|
| 2009 |
Paker-Leggs S, Neau SH. Pellet characteristics and drug release when the form of propranolol is fixed as moles or mass in formulations for extruded and spheronized Carbopol-containing pellets. International Journal of Pharmaceutics. 369: 96-104. PMID 19041699 DOI: 10.1016/J.Ijpharm.2008.11.002 |
0.536 |
|
| 2008 |
Paker-Leggs S, Neau SH. Propranolol forms affect properties of Carbopol-containing extruded-spheronized beads. International Journal of Pharmaceutics. 361: 169-76. PMID 18601988 DOI: 10.1016/J.Ijpharm.2008.05.041 |
0.517 |
|
| 2006 |
Bommareddy GS, Paker-Leggs S, Saripella KK, Neau SH. Extruded and spheronized beads containing Carbopol 974P to deliver nonelectrolytes and salts of weakly basic drugs. International Journal of Pharmaceutics. 321: 62-71. PMID 16828248 DOI: 10.1016/j.ijpharm.2006.05.017 |
0.448 |
|
| 2006 |
Howard MA, Neau SH, Sack MJ. PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC. International Journal of Pharmaceutics. 307: 66-76. PMID 16253448 DOI: 10.1016/j.ijpharm.2005.09.021 |
0.44 |
|
| 2005 |
Alsarra LA, Bosela AA, Al-Mohizea AM, Mahrous GM, Neau SH. Modulatinn Intestinal Uptake of Atenolol Usinn Niosomes as Drun Permeation Enhancers Scientia Pharmaceutica. 73: 81-93. DOI: 10.3797/Scipharm.Aut-05-07 |
0.521 |
|
| 2005 |
Alsarra IA, Bosela AA, Al-Mohizea AM, Mahrous GM, Neau SH. Modulating intestinal uptake of Atenolol using niosomes as drug permeation enhancers Scientia Pharmaceutica. 73: 81-93. |
0.429 |
|
| 2004 |
Agrawal AM, Howard MA, Neau SH. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables. Pharmaceutical Development and Technology. 9: 197-217. PMID 15202579 DOI: 10.1081/PDT-120030250 |
0.396 |
|
| 2003 |
Agrawal AM, Neau SH, Bonate PL. Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release. Aaps Pharmsci. 5: E13. PMID 12866940 DOI: 10.1208/ps050213 |
0.481 |
|
| 2001 |
Desai RP, Neau SH, Pather SI, Johnston TP. Fine-particle ethylcellulose as a tablet binder in direct compression, immediate-release tablets Drug Development and Industrial Pharmacy. 27: 633-641. PMID 11694010 DOI: 10.1081/DDC-100107319 |
0.347 |
|
| 2000 |
Neau SH, Chow MY, Hileman GA, Durrani MJ, Gheyas F, Evans BA. Formulation and process considerations for beads containing Carbopol 974P, NF resin made by extrusion-spheronization. International Journal of Pharmaceutics. 199: 129-40. PMID 10802406 DOI: 10.1016/S0378-5173(00)00372-0 |
0.427 |
|
| 1999 |
Neau SH, Howard MA, Claudius JS, Howard DR. The effect of the aqueous solubility of xanthine derivatives on the release mechanism from ethylcellulose matrix tablets. International Journal of Pharmaceutics. 179: 97-105. PMID 10053206 DOI: 10.1016/S0378-5173(98)00391-3 |
0.431 |
|
| 1998 |
Pather SI, Russell I, Syce JA, Neau SH. Sustained release theophylline tablets by direct compression Part 1: Formulation and in vitro testing International Journal of Pharmaceutics. 164: 1-10. DOI: 10.1016/S0378-5173(97)00348-7 |
0.401 |
|
| 1997 |
Hileman GA, Upadrashta SM, Neau SH. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets Pharmaceutical Development and Technology. 2: 43-52. PMID 9552430 |
0.391 |
|
| 1995 |
Katikaneni PR, Upadrashta SM, Neau SH, Mitra AK. Ethylcellulose matrix controlled release tablets of a water-soluble drug International Journal of Pharmaceutics. 123: 119-125. DOI: 10.1016/0378-5173(95)00060-V |
0.451 |
|
| 1994 |
Häglund BO, Upadrashta SM, Neau SH, Cutrera MA. Dissolution controlled drug release from agarose beads Drug Development and Industrial Pharmacy. 20: 947-959. DOI: 10.3109/03639049409038343 |
0.375 |
|
| 1993 |
Parikh BV, Upadrashta SM, Neau SH, Nuessle NO. Oestrone loaded poly(l-lactic acid) microspheres: Preparation, evaluation and in vitro release kinetics Journal of Microencapsulation. 10: 141-153. PMID 8331489 DOI: 10.3109/02652049309104380 |
0.319 |
|
| 1990 |
Neau SH, Flynn GL. Solid and Liquid Heat Capacities of n-Alkyl Para-aminobenzoates Near the Melting Point Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 7: 1157-1162. PMID 2293215 DOI: 10.1023/A:1015984310068 |
0.473 |
|
| 1989 |
Neau SH, Flynn GL, Yalkowsky SH. The influence of heat capacity assumptions on the estimation of solubility parameters from solubility data International Journal of Pharmaceutics. 49: 223-229. DOI: 10.1016/0378-5173(89)90346-3 |
0.482 |
|
| Show low-probability matches. |